We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical (EMN) to Bump Up Prices of Amines Products
Read MoreHide Full Article
Eastman Chemical Company (EMN - Free Report) has announced that it will raise prices of the Amines products effective Feb 1, 2019 or as contracts permit.
The company will increase the global prices of all Synergex products, Dibutylaminoethanol (DBAE), Dimethylamino-2 Propanol (DMA2P-77 and Anhydrous), Ethylaminoethanol (EAE), Isopropylaminoethanol (IPAE), N-Butylaminoethanol (BAE)N-Butyldiethanolamine (BDEA) and T-Butylaminoethanol (TBAE) products by 8 cents per lb and $176/MT.
Moreover, in North and Latin America, the company will raise prices of Amietol M11, Amietol M12 and Amietol M21 by 5 cents per lb and $110/MT.
Eastman Chemical is taking actions to raise selling prices of products in the wake of raw material price inflation. Higher selling prices of most product lines contributed to revenue growth at the company’s Additives & Functional Products and Chemical Intermediates segments during the third quarter of 2018.
In a year’s time, shares of Eastman Chemical have outperformed the industry it belongs to. The stock has lost around 26.4% compared with the industry’s fall of 30.9%.
On third-quarter 2018 earnings call, Eastman Chemical noted that strong volume gains in the specialty businesses, disciplined cost management and a lower effective tax rate helped it achieve a year-over-year adjusted earnings per share growth rate of 13% during the first nine months of 2018. The company consistently expects a year-over-year adjusted earnings per share rise of 10-14%.
The company is focused on productivity and cost-cutting actions, aiding it to offset raw material cost inflation and other cost headwinds. Eastman Chemical anticipates to deliver $100 million savings under its cost-reduction program.
Eastman Chemical has been seeing a rise in raw materials costs, mostly in its chemical intermediates business as witnessed in the third quarter. Raw materials cost woe is anticipated to persist. Nevertheless, the company’s productivity and price-hike actions are likely to enable it to offset the input cost pressure.
Ingevity has an expected earnings growth rate of 21.5% for 2019 and a Zacks Rank #2 (Buy). The stock has rallied 8% in a year.
Cameco has an expected earnings growth rate of 20% for 2019 and a Zacks Rank #2. Its shares have gained 15.3% in a year’s time.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Eastman Chemical (EMN) to Bump Up Prices of Amines Products
Eastman Chemical Company (EMN - Free Report) has announced that it will raise prices of the Amines products effective Feb 1, 2019 or as contracts permit.
The company will increase the global prices of all Synergex products, Dibutylaminoethanol (DBAE), Dimethylamino-2 Propanol (DMA2P-77 and Anhydrous), Ethylaminoethanol (EAE), Isopropylaminoethanol (IPAE), N-Butylaminoethanol (BAE)N-Butyldiethanolamine (BDEA) and T-Butylaminoethanol (TBAE) products by 8 cents per lb and $176/MT.
Moreover, in North and Latin America, the company will raise prices of Amietol M11, Amietol M12 and Amietol M21 by 5 cents per lb and $110/MT.
Eastman Chemical is taking actions to raise selling prices of products in the wake of raw material price inflation. Higher selling prices of most product lines contributed to revenue growth at the company’s Additives & Functional Products and Chemical Intermediates segments during the third quarter of 2018.
In a year’s time, shares of Eastman Chemical have outperformed the industry it belongs to. The stock has lost around 26.4% compared with the industry’s fall of 30.9%.
On third-quarter 2018 earnings call, Eastman Chemical noted that strong volume gains in the specialty businesses, disciplined cost management and a lower effective tax rate helped it achieve a year-over-year adjusted earnings per share growth rate of 13% during the first nine months of 2018. The company consistently expects a year-over-year adjusted earnings per share rise of 10-14%.
The company is focused on productivity and cost-cutting actions, aiding it to offset raw material cost inflation and other cost headwinds. Eastman Chemical anticipates to deliver $100 million savings under its cost-reduction program.
Eastman Chemical has been seeing a rise in raw materials costs, mostly in its chemical intermediates business as witnessed in the third quarter. Raw materials cost woe is anticipated to persist. Nevertheless, the company’s productivity and price-hike actions are likely to enable it to offset the input cost pressure.
Eastman Chemical Company Price and Consensus
Eastman Chemical Company Price and Consensus | Eastman Chemical Company Quote
Zacks Rank & Stocks to Consider
Eastman Chemical currently carries a Zacks Rank #4 (Sell).
A few better-ranked stocks in the basic materials space are Verso Corp. , Ingevity Corp. (NGVT - Free Report) and Cameco Corp. (CCJ - Free Report) .
Verso has an expected earnings growth rate of 63.5% for 2019 and a Zacks Rank #1 (Strong Buy). The company’s shares have surged 33.7% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Ingevity has an expected earnings growth rate of 21.5% for 2019 and a Zacks Rank #2 (Buy). The stock has rallied 8% in a year.
Cameco has an expected earnings growth rate of 20% for 2019 and a Zacks Rank #2. Its shares have gained 15.3% in a year’s time.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>